Clinical Trial

The BD Liverty™ TIPS Stent Graft Study

Study acronym: ARCH
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
Protocol Amendment History 7 changes
critical Trial status changed: Withheld → Active, Not Recruiting 2026-07-19
critical Phase changed: not specified -> not applicable 2026-07-19
critical Primary endpoint(s) modified 2026-07-19
notable Enrollment changed: None -> 177 2026-07-19
notable Sponsor changed: [Redacted] -> C. R. Bard 2026-07-19
minor Trial arms changed: 0 -> 1 2026-07-19
notable Trial sites expanded: 0 -> 26 locations 2026-07-19
Trial Details
NCT Number NCT05711316
Lead Sponsor C. R. Bard
Conditions Portal Hypertension, TIPS
Enrollment 177 participants
Start Date 2023-08-08
Primary Completion 2025-06-23 (estimated)
Study Completion 2027-01-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-20